CDSCO-2022-0053-V353

Type IB variation for application CDSCO-2022-0053. Type IB variation: Facility Change for Upadacitimab — minor update

Variation Number
CDSCO-2022-0053-V353
Type
Type IB
Application
CDSCO-2022-0053
Change
CHG-2024-0053
Status
Overdue
Fee
€4,347
Submitted
2022-11-14
Approved
—
Description

Type IB variation: Facility Change for Upadacitimab — minor update